XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows used in operating activities:    
Net income $ 12,684 $ 11,329
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 3,720 4,147
Bad debt provision 6,907 2,851
Deferred income tax benefit 43 0
Share-based compensation expense 2,058 2,396
Amortization of premium on marketable securities 533 561
Unrealized (gain) loss on deferred compensation fund investments (1,502) 4,074
Changes in other long-term liabilities 336 (1,760)
Net loss on disposals of fixed assets 128 173
Changes in operating assets and liabilities:    
Accounts and notes receivable (20,633) (27,222)
Inventories and supplies 935 1,195
Prepaid expenses and other assets 4,076 (2,462)
Deferred compensation funding 683 3,605
Accounts payable and other accrued expenses (6,422) (3,051)
Accrued payroll, accrued and withheld payroll taxes (21,167) (24,933)
Income taxes receivable (1,748) 3,764
Accrued insurance claims 2,366 3,056
Deferred compensation liability 713 (7,905)
Net cash used in operating activities (16,290) (30,182)
Cash flows used in investing activities:    
Disposals of fixed assets 57 152
Additions to property and equipment (1,010) (1,407)
Purchases of marketable securities 0 (1,525)
Sales of marketable securities 210 1,519
Cash paid for acquisitions 0 (114)
Net cash used in investing activities (743) (1,375)
Cash flows from (used in) financing activities:    
Dividends paid 0 (15,704)
Reissuance of treasury stock pursuant to Dividend Reinvestment Plan 0 25
Proceeds from the exercise of stock options 0 410
Purchases of treasury stock (2,223) 0
Proceeds from short-term borrowings 10,000 10,000
Payments of statutory withholding on net issuance of restricted stock units (870) (1,069)
Net cash from (used in) financing activities 6,907 (6,338)
Net change in cash and cash equivalents (10,126) (37,895)
Cash and cash equivalents at beginning of the period 26,279 70,794
Cash and cash equivalents at end of the period $ 16,153 $ 32,899